ArticleProceedings of the National Academy of Sciences of the United States of America2009

IGFBP2 is a candidate biomarker for Ink4a-Arf status and a therapeutic target for high-grade gliomas.

Lynette M Moore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.